MedTrace Logo

Functional Assessment in Liver Transplantation

NCT03870568 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 411

Last updated 2026-01-27

No results posted yet for this study

Summary

In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.

Conditions

  • Cirrhosis
  • End Stage Liver Disease

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • James Trotter, MD · Baylor Health Care System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-06
Primary Completion
2024-05-08
Completion
2024-05-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870568 on ClinicalTrials.gov